Literature DB >> 22277057

Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.

Andrea J Vernall1, Leigh A Stoddart, Stephen J Briddon, Stephen J Hill, Barrie Kellam.   

Abstract

The adenosine-A(3) receptor (A(3)AR) is a G protein-coupled receptor that shows promise as a therapeutic target for cancer, glaucoma, and various autoimmune inflammatory disorders, and as such, there is a need for molecular probes to study this receptor. Here, we report a series of fluorescent ligands containing different linkers and fluorophores based around a 1,2,4-triazolo[4,3-a]quinoxalin-1-one antagonist. One of these conjugates (19) displayed high affinity for the A(3)AR (pK(D) = 9.36 ± 0.12) and is >650-fold selective over other adenosine receptor subtypes. Confocal microscopy revealed clear, displaceable membrane labeling of CHO-A(3) cells with 19, with no detectable labeling of CHO-A(1) cells under identical conditions. This fluorescent ligand was also able to specifically label the A(3)AR in HEK293T cells containing a mixed adenosine receptor population. The subtype specificity, along with its excellent imaging properties, make 19 an ideal tool for studying A(3)AR distribution and organization, particularly in the presence of other adenosine receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277057     DOI: 10.1021/jm201722y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

2.  Synthesis of BODIPY derivatives substituted with various bioconjugatable linker groups: a construction kit for fluorescent labeling of receptor ligands.

Authors:  Fabian Heisig; Sabrina Gollos; Sven J Freudenthal; Ali El-Tayeb; Jamshed Iqbal; Christa E Müller
Journal:  J Fluoresc       Date:  2013-09-20       Impact factor: 2.217

3.  Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor.

Authors:  Zhi Yuan Kok; Leigh A Stoddart; Sarah J Mistry; Tamara A M Mocking; Henry F Vischer; Rob Leurs; Stephen J Hill; Shailesh N Mistry; Barrie Kellam
Journal:  J Med Chem       Date:  2022-06-03       Impact factor: 8.039

4.  Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression.

Authors:  Mark J Wall; Emily Hill; Robert Huckstepp; Kerry Barkan; Giuseppe Deganutti; Michele Leuenberger; Barbara Preti; Ian Winfield; Sabrina Carvalho; Anna Suchankova; Haifeng Wei; Dewi Safitri; Xianglin Huang; Wendy Imlach; Circe La Mache; Eve Dean; Cherise Hume; Stephanie Hayward; Jess Oliver; Fei-Yue Zhao; David Spanswick; Christopher A Reynolds; Martin Lochner; Graham Ladds; Bruno G Frenguelli
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

5.  Characterization by flow cytometry of fluorescent, selective agonist probes of the A(3) adenosine receptor.

Authors:  Eszter Kozma; Elizabeth T Gizewski; Dilip K Tosh; Lucia Squarcialupi; John A Auchampach; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2013-01-31       Impact factor: 5.858

Review 6.  Fluorescent ligands for adenosine receptors.

Authors:  Eszter Kozma; P Suresh Jayasekara; Lucia Squarcialupi; Silvia Paoletta; Stefano Moro; Stephanie Federico; Giampiero Spalluto; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2012-11-05       Impact factor: 2.823

7.  Nanomolar-Potency 1,2,4-Triazoloquinoxaline Inhibitors of the Kidney Urea Transporter UT-A1.

Authors:  Sujin Lee; Onur Cil; Elena Diez-Cecilia; Marc O Anderson; Alan S Verkman
Journal:  J Med Chem       Date:  2018-04-03       Impact factor: 7.446

8.  Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels.

Authors:  Joëlle Goulding; Sarah J Mistry; Mark Soave; Jeanette Woolard; Stephen J Briddon; Carl W White; Barrie Kellam; Stephen J Hill
Journal:  Pharmacol Res Perspect       Date:  2021-05

9.  Application of BRET to monitor ligand binding to GPCRs.

Authors:  Stephen J Hill; Kevin D G Pfleger; Leigh A Stoddart; Elizabeth K M Johnstone; Amanda J Wheal; Joëlle Goulding; Matthew B Robers; Thomas Machleidt; Keith V Wood
Journal:  Nat Methods       Date:  2015-06-01       Impact factor: 28.547

Review 10.  Biophysical Detection of Diversity and Bias in GPCR Function.

Authors:  Werner C Jaeger; Stephen P Armstrong; Stephen J Hill; Kevin D G Pfleger
Journal:  Front Endocrinol (Lausanne)       Date:  2014-03-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.